EUVIMEDEUVIMED entdecken
Crossref

Ceftazidime/avibactam and eravacycline susceptibility of carbapenem-resistant Klebsiella pneumoniae in two Greek tertiary teaching hospitals

Maria Chatzidimitriou iD, Panagiota Chatzivasileiou, Georgios Sakellariou, MariaAnna Kyriazidi, Asimoula Kavvada, Dimitris Chatzidimitriou, Fani Chatzopoulou, Georgios Meletis, Maria Mavridou, Dimitris Rousis, Eleni Katsifa, Eleni Vagdatli und 2 weitere

Acta Microbiologica et Immunologica Hungarica · 21.06.2021 · 68 (2) · 65-72

DOI: 10.1556/030.2021.01364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, erschienen am 21.06.2021. Verfasst von Maria Chatzidimitriou und 13 weiteren Autor:innen. Beteiligte Einrichtung: 1School of Biomedical Sciences, International Hellenic University, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Klebsiella Infections, Klebsiella pneumoniae. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study evaluated the carbapenem resistance mechanisms of Klebsiella pneumoniae strains isolated in two Greek tertiary teaching hospitals and their susceptibility to currently used and novel antimicrobial agents. Forty-seven carbapenem resistant K. pneumoniae strains were collected in G. Papanikolaou and Ippokrateio hospital of Thessaloniki between 2016 and 2018. Strain identification and antimicrobial susceptibility was conducted by Vitek 2 system (Biomérieux France). Susceptibility against new antimicrobial agents was examined by disk diffusion method. Polymerase chain reaction (PCR) was used to detect bla KPC , bla VIM , bla NDM and bla OXA-48 genes. The meropenem–EDTA and meropenem–boronic acid synergy test performed on the 24 K. pneumoniae strains demonstrated that 8 (33.3%) yielded positive for metallo-beta-lactamases (MBL) and 16 (66.6%) for K. pneumonia carbapenemases (KPC) production. Colistin demonstrated the highest in vitro activity (87.7%) among the 47 K. pneumoniae strains followed by gentamicin (76.5%) and tigecycline (51%). Among new antibiotics ceftazidime/avibactam showed the highest sensitivity (76.6%) in all strains followed by eravacycline (66.6%). The bla KPC gene was present in 30 strains (63.8%), the bla NDM in 11 (23.4%) and the bla VIM in 6 (12.8%). The bla OXA-48 gene was not detected. Well established antimicrobial agents such as colistin, gentamicin and tigecycline and novel antibiotics like ceftazidime/avibactam and eravacycline can be reliable options for the treatment of invasive infections caused by carbapenem-resistant K. pneumoniae .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella InfectionsKlebsiella pneumoniaeAnti-Bacterial AgentsAzabicyclo CompoundsBacterial ProteinsCarbapenemsCeftazidimeGreeceHospitals, TeachingHumansMicrobial Sensitivity TestsTetracyclinesbeta-Lactamases

Stichwörter der Autor:innen

K. pneumoniaecarbapenem-resistancecarbapenemasescarbapenems

Substanzen

Anti-Bacterial AgentsAzabicyclo CompoundsBacterial ProteinsCarbapenemsTetracyclineseravacyclineavibactamCeftazidimebeta-Lactamases

Autor:innen und Institutionen

  • 1School of Biomedical Sciences, International Hellenic University, Thessaloniki, Greece.
  • 2Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • 3Medical School, Demokritus University of Thrace, Thessaloniki, Greece.
  • 4General Teaching Hospital "G. Papanikolaou", Thessaloniki, Greece.
  • 5General Teaching Hospital "Ippokrateio", Thessaloniki, Greece.

ORCID-Profile: Maria Chatzidimitriou

Zitieren

APA

Chatzidimitriou, M., Chatzivasileiou, P., Sakellariou, G., Kyriazidi, M., Kavvada, A., Chatzidimitriou, D., Chatzopoulou, F., Meletis, G., Mavridou, M., Rousis, D., Katsifa, E., Vagdatli, E., Mitka, S., & Theodoros, L. (2021). Ceftazidime/avibactam and eravacycline susceptibility of carbapenem-resistant Klebsiella pneumoniae in two Greek tertiary teaching hospitals. Acta Microbiologica et Immunologica Hungarica, 68(2), 65-72. https://doi.org/10.1556/030.2021.01364

Vancouver

Chatzidimitriou M, Chatzivasileiou P, Sakellariou G, Kyriazidi M, Kavvada A, Chatzidimitriou D, et al. Ceftazidime/avibactam and eravacycline susceptibility of carbapenem-resistant Klebsiella pneumoniae in two Greek tertiary teaching hospitals. Acta Microbiologica et Immunologica Hungarica. 2021;68(2):65-72. doi:10.1556/030.2021.01364

BibTeX
@article{Chatzidimitriou2021,
  author = {Chatzidimitriou, Maria and Chatzivasileiou, Panagiota and Sakellariou, Georgios and Kyriazidi, MariaAnna and Kavvada, Asimoula and Chatzidimitriou, Dimitris and Chatzopoulou, Fani and Meletis, Georgios and Mavridou, Maria and Rousis, Dimitris and Katsifa, Eleni and Vagdatli, Eleni and Mitka, Stella and Theodoros, Lialiaris},
  title = {Ceftazidime/avibactam and eravacycline susceptibility of carbapenem-resistant Klebsiella pneumoniae in two Greek tertiary teaching hospitals},
  journal = {Acta Microbiologica et Immunologica Hungarica},
  year = {2021},
  volume = {68},
  number = {2},
  pages = {65--72},
  doi = {10.1556/030.2021.01364}
}
Kostenlos starten →